Paper40144468
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.
Shinkawa H and 14 others. Liver Cancer, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study. Papers, record 40144468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40144468
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37364790 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | J Hepatol | 2023 | https://conductscience.org/library/papers/37364790 | PubMed |
| 2 | 18387499 | Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. | Clin Gastroenterol Hepatol | 2008 | https://conductscience.org/library/papers/18387499 | PubMed |
| 3 | 26488173 | General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan. | Dig Dis | 2015 | https://conductscience.org/library/papers/26488173 | PubMed |
| 4 | 37998747 | The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37998747 | PubMed |
| 5 | 38264220 | Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 Diabetes. | Diabetol Int | 2024 | https://conductscience.org/library/papers/38264220 | PubMed |
| 6 | 16844421 | Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16844421 | PubMed |
| 7 | 30240472 | Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C. | J Gastrointestin Liver Dis | 2018 | https://conductscience.org/library/papers/30240472 | PubMed |
| 8 | 15753540 | Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. | Gut | 2005 | https://conductscience.org/library/papers/15753540 | PubMed |
| 9 | 12502618 | Standards of medical care for patients with diabetes mellitus. | Diabetes Care | 2003 | https://conductscience.org/library/papers/12502618 | PubMed |
| 10 | 36565361 | Association between diabetes and cancer. Current mechanistic insights into the association and future challenges. | Mol Cell Biochem | 2023 | https://conductscience.org/library/papers/36565361 | PubMed |
| 11 | 29628281 | EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. | J Hepatol | 2018 | https://conductscience.org/library/papers/29628281 | PubMed |
| 12 | 33442538 | Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update. | Liver Cancer | 2020 | https://conductscience.org/library/papers/33442538 | PubMed |
| 13 | 33952449 | Obesity and Liver Cancer in Japan: A Comprehensive Review. | Anticancer Res | 2021 | https://conductscience.org/library/papers/33952449 | PubMed |
| 14 | 11420485 | Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. | Ann Surg | 2001 | https://conductscience.org/library/papers/11420485 | PubMed |
| 15 | 28320770 | High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men. | Gut | 2018 | https://conductscience.org/library/papers/28320770 | PubMed |
| 16 | 14726171 | Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. | Lancet | 2004 | https://conductscience.org/library/papers/14726171 | PubMed |
| 17 | 20109902 | The metabolic syndrome. | Lancet | 2010 | https://conductscience.org/library/papers/20109902 | PubMed |
| 18 | 26523206 | Era of direct acting antivirals in chronic hepatitis C: Who will benefit? | World J Hepatol | 2015 | https://conductscience.org/library/papers/26523206 | PubMed |
| 19 | 20175765 | Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. | Aliment Pharmacol Ther | 2010 | https://conductscience.org/library/papers/20175765 | PubMed |
| 20 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959204 | Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma. | Glob Health Med | 2026 | https://conductscience.org/library/papers/42959204 | PubMed |
| 42802761 | Associations of Type 2 Diabetes with Tumor Budding and Microvascular Invasion in Resected Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42802761 | PubMed |
| 42703506 | Metabolic burden but not metabolic dysfunction-associated steatotic liver disease affects the prognosis of patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42703506 | PubMed |
| 42630561 | Evidence summary on perioperative blood glucose management in liver cancer patients. | Front Oncol | 2026 | https://conductscience.org/library/papers/42630561 | PubMed |
| 42592470 | Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review. | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42592470 | PubMed |
| 42506450 | The Liver Left Behind: GLP-1 Receptor Agonists and the Prospect of Metabolic Adjuvant Therapy After HCC Resection. | Metabolites | 2026 | https://conductscience.org/library/papers/42506450 | PubMed |
| 42400215 | Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42400215 | PubMed |
| 42363084 | Development and validation of a nomogram to predict recurrence after hepatectomy in overweight patients with hepatocellular carcinoma: a retrospective cohort study. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42363084 | PubMed |
| 42045721 | ASO Author Reflections: Is Intervening in Metabolic Syndrome a New Direction for Improving the Prognosis After Curative-Intent Resection of Perihilar Cholangiocarcinoma? | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42045721 | PubMed |
| 41896509 | Association Between Metabolic Syndrome and Long-Term Prognosis in Patients with Perihilar Cholangiocarcinoma Treated with Curative-Intent Resection: A Multicenter Study. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41896509 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40144468
GET https://conductscience.org/api/papers/v1/40144468/references?page=2